in 2020 demonstrated the brain targeting peptides (apolipoprotein-E [ApoE] and rabies virus glycoprotein [RVG]) modified gold liposomes (30-50 nm) for siRNA delivery against dysregulated mRNA in GBM. The gene discussed is APOE; the disease is glioblastoma.